20 Pancreatic Cancer Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting Pancreatic Cancer Studies in New York

NCT02000089Recruiting

The Cancer of the Pancreas Screening-5 CAPS5)Study

Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at thei...

New York, NYPHASE39,000 participantsJohns Hopkins University

View Study Details

NCT01102556Recruiting

PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease

The specific aims of this project are to create a registry, as well as a biospecimen bank for individuals with pancreatic disease (e.g. pancreatic adenocarcinoma, pancreatitis, intraductal papillary m...

New York, NY1,000 participantsColumbia University

View Study Details

NCT07491445Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

The purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combination with chemotherapy, compared with standard of care...

New York, NYPHASE3900 participantsRevolution Medicines, Inc.

View Study Details

NCT05254171Recruiting

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

The study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-101 in subjects previously untreated for me...

New York, NYPHASE2600 participantsPanbela Therapeutics, Inc.

View Study Details

NCT02393703Recruiting

Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer

The purpose of this study is to isolate and analyze exosomes, which are tiny carriers of important proteins and nucleic acids that serve as messenger systems in the blood and tissue. Blood and tissue ...

New York, NY181 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06458712Recruiting

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Open label, multi-centre, Phase Ia/b adaptive design study with an initial 2-stage Dose Escalation Phase followed by a Dose Expansion Phase....

New York, NYPHASE1180 participantsDuke Street Bio Ltd

View Study Details

NCT07049055Recruiting

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

The purpose of this study is to evaluate the safety and tolerability and overall survival (OS) of E-EDV-D682/GC in combination with gemcitabine and nab-paclitaxel versus gemcitabine and nab-paclitaxel...

New York, NYPHASE1144 participantsEngeneic Pty Limited

View Study Details

NCT03334708Recruiting

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

The purpose of this study is to develop a minimally invasive test to diagnose pancreatic cancer at early stages of disease and monitor response to treatment....

New York, NY120 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT01102569Recruiting

Pancreatic Cancer Genetics

The aim of this study is to determine the frequency of the three most common BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2) genetic mutations that are commonly found in Ashkenazi Jewish...

New York, NY100 participantsColumbia University

View Study Details

NCT07270237Recruiting

A Study of Multiparametric Ultrasound Imaging Methods

The researchers are doing this study to see how well a type of ultrasound imaging called multiparametric ultrasound (mpUS), can be used to examine, evaluate, and provide information about different ca...

New York, NYNA85 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07612046Recruiting

A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening

The purpose of this study is to develop a dedicated MRI scan of the pancreas (MRP) to better detect pancreatic cancer in people who are at a high risk for pancreatic cancer....

New York, NY79 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05851924Recruiting

A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

The researchers are doing this study to find out whether using the chemotherapy regimen NALIRIFOX in combination with ablative dose radiation therapy (AD-XRT) and the standard chemotherapy drug capeci...

New York, NYPHASE260 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06048484Recruiting

Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

The purpose of this study is to combine standard radiation therapy with drugs that encourages the body's immune system against cancer cells and simultaneously adding drugs which also target the pathwa...

New York, NYPHASE260 participantsGulam Manji

View Study Details

NCT06698458Recruiting

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

This is a multi-center clinical study enrolling up to 30 participants (15 patients in each cohort). The primary objective of the study is to evaluate the safety of Alpha DaRT in combination with chemo...

New York, NYNA40 participantsAlpha Tau Medical LTD.

View Study Details

NCT07450859Recruiting

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

This is a Phase 2 study for nuzefatide pevedotin (BT5528) in adults with a specific type of pancreatic cancer called metastatic pancreatic ductal adenocarcinoma (PDAC) that has spread and worsened aft...

New York, NYPHASE239 participantsBicycleTx Limited

View Study Details

NCT05462496Recruiting

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

A multi-institutional, single arm pilot study of antibiotics and pembrolizumab, following chemotherapy for the treatment of surgically resectable pancreatic cancer....

New York, NYPHASE225 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT04150042Recruiting

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

The clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on metastatic pancreatic cancer and metastatic breast cancer. The investigational treat...

New York, NYPHASE124 participantsGeneral Oncology, Inc.

View Study Details

NCT07671339Recruiting

A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer

The researchers are doing this study to find out whether ELI-002 7P in combination with mFOLFIRINOX, with or without tislelizumab, is a safe treatment approach in people who have pancreatic ductal ade...

New York, NYPHASE120 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05723107Recruiting

EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)

This is a single arm study in the treatment of pancreatic ductal adenocarcinoma (PDAC). The investigators propose to test the tolerability of chemotherapy plus endoscopic ultrasound-guided radiofreque...

New York, NYPHASE115 participantsNYU Langone Health

View Study Details

NCT04543071Recruiting

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

The purpose of this study is to determine if combination treatment with cemiplimab, motixafortide, gemcitabine, and nab-paclitaxel is effective in decreasing the size of the tumor(s), if it will prolo...

New York, NYPHASE210 participantsGulam Manji

View Study Details

About Pancreatic Cancer Clinical Trials in New York

Pancreatic cancer begins in the tissues of the pancreas and is often diagnosed at an advanced stage. It is one of the most challenging cancers to treat. Clinical trials are actively investigating new approaches including immunotherapy and combination regimens.

There are currently 20 pancreatic cancer clinical trials recruiting participants in New York, NY. These studies are seeking a combined 12,682 participants. Research is being sponsored by Johns Hopkins University, Columbia University, Revolution Medicines, Inc. and 10 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pancreatic Cancer Clinical Trials in New York — FAQ

Are there pancreatic cancer clinical trials in New York?

Yes, there are 20 pancreatic cancer clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What pancreatic cancer treatments are being tested?

The 20 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for pancreatic cancer.

Data updated July 16, 2026 from ClinicalTrials.gov